Bovine lactoferrin maintains antibacterial effect against neonatal Escherichia coli septicaemia isolates despite the presence of iron acquisition genes
Journal of Medical Microbiology · 21.01.2026 · 75 (1)
DOI: 10.1099/jmm.0.002116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 21.01.2026. Verfasst von Matthew Mayorga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City University College of Osteopathic Medicine, Kansas City, MO, USA. Hauptthemen laut MEDLINE: Lactoferrin, Escherichia coli, Iron, Escherichia coli Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Herbert A. Wenner Fellowship Award, Children’s Mercy Research Institute Research Partners Innovation Award.
Abstract (Originalsprache)
Introduction
Escherichia coli is a dominant cause of neonatal sepsis for which no prevention measures currently exist. Lactoferrin (LF) is an iron-sequestering antibacterial protein that has been noticed to decrease neonatal late-onset sepsis. Hypothesis/Gap Statement. LF’s effect on in vitro growth of neonatal E. coli clinical isolates causing septicaemia is unknown. The prevalence of iron acquisition virulence genes which contribute to pathogenicity outcomes in these strains has also not been described in detail.
Aim
To evaluate bovine lactoferrin’s (bLF) effects on the in vitro growth of neonatal septicaemia E. coli isolates, and to determine the presence of iron acquisition virulence genes in these isolates. Methodology. E. coli clinical strains isolated from blood of septic neonates, including the archetypal RS218 strain, all representing prevalent phylogroups and multi-locus sequence types among neonatal invasive strains were studied. Strains were grown in batch growth with 0, 0.1, 1.0 and 10 mg ml −1 bLF. OD measurements over time were used to generate growth curves, and the area under these curves was statistically compared using ANOVA or Kruskal–Wallis tests. Whole-genome sequencing (WGS) data were used to identify iron acquisition genes.
Results
For all strains, growth decrease with 10 mg ml −1 bLF compared to zero was highly significant ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kansas City University College of Osteopathic Medicine, Kansas City, MO, USA.
- Division of Infectious Diseases, Children's Mercy Kansas City, Kansas City, MO, USA.
- Present address: Kansas Department of Health and Environment, Topeka, KS, USA.
- University of Missouri Kansas City School of Medicine, Kansas City, MO, USA.
Förderung
- Herbert A. Wenner Fellowship Award
- Children’s Mercy Research Institute Research Partners Innovation Award
Zitieren
APA
Mayorga, M., Wheatley, J. L., Maldonado, B. N., & Chavez-Bueno, S. (2026). Bovine lactoferrin maintains antibacterial effect against neonatal Escherichia coli septicaemia isolates despite the presence of iron acquisition genes. Journal of Medical Microbiology, 75(1). https://doi.org/10.1099/jmm.0.002116
Vancouver
Mayorga M, Wheatley JL, Maldonado BN, Chavez-Bueno S. Bovine lactoferrin maintains antibacterial effect against neonatal Escherichia coli septicaemia isolates despite the presence of iron acquisition genes. Journal of Medical Microbiology. 2026;75(1). doi:10.1099/jmm.0.002116
BibTeX
@article{Mayorga2026,
author = {Mayorga, Matthew and Wheatley, Joshua L and Maldonado, Brianna N and Chavez-Bueno, Susana},
title = {Bovine lactoferrin maintains antibacterial effect against neonatal Escherichia coli septicaemia isolates despite the presence of iron acquisition genes},
journal = {Journal of Medical Microbiology},
year = {2026},
volume = {75},
number = {1},
doi = {10.1099/jmm.0.002116}
}
EUVIMED